T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes

Clinical and Experimental Immunology

Volumn 172, Issue 2, 2013, Pages 245-253

  Zimmermann, C ^a   Weber, A ^a   Mausberg, A K ^a   Kieseier, B C ^a   Hartung, H P ^a   Hofstetter, H H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Animal models studies mice rats; CD4 T cells (T helper; Th0, Th1, Th2, Th3, Th17); Inflammation inflammatory mediators including eicosanoids; T cells; Thymus

Indexed keywords

BACTERIAL DNA; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 6; ZYMOSAN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; EX VIVO STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ANTIGENS, CD3; DNA, BACTERIAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESCHERICHIA COLI; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYELIN PROTEOLIPID PROTEIN; SPLEEN; T-LYMPHOCYTES; THYMOCYTES; ZYMOSAN;

EID: 84876098185     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12037     Document Type: Article

References (29)

1. Giamarellos-Bourboulis EJ. What is the pathophysiology of the septic host upon admission? Int J Antimicrob Agents 2010; 36 (Suppl. 2):S2-5.
2. Cristofaro P, Opal SM. The Toll-like receptors and their role in septic shock. Exp Opin Ther Targets 2003; 7:603-612.
3. Li J, Carr B, Goyal M, Gaieski DF. Sepsis: the inflammatory foundation of pathophysiology and therapy. Hosp Pract (Minn) 2011; 39:99-112.
4. Billard MJ, Gruver AL, Sempowski GD. Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS ONE 2011; 6:e17940.
5. Wang SD, Huang KJ, Lin YS, Lei HY. Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 1994; 152:5014-5021.
6. Saitoh S, Miyake K. Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev 2009; 227:32-43.
7. Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 2011; 52:379-392.
8. Matsui N, Nitta T, Takahama Y. [Development of the thymus and immune system]. Brain Nerve 2011; 63:679-684.
9. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197:1107-1117.
10. Gupta GK, Agrawal DK. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010; 24:225-235.
11. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709-760.
12. Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007; 19:362-371.
13. Hofstetter HH, Luhder F, Toyka KV, Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine 2006; 34:184-197.
14. Kim JS, Smith-Garvin JE, Koretzky GA, Jordan MS. The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J Exp Med 2011; 208:2201-2207.
15. Marks BR, Nowyhed HN, Choi JY etal. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 2009; 10:1125-1132.
16. Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011; 11:807-822.
17. Oberg HH, Juricke M, Kabelitz D, Wesch D. Regulation of T cell activation by TLR ligands. Eur J Cell Biol 2011; 90:582-592.
18. Smolianov V, Dehmel T, Kieseier BC, Hemmer B, Hartung HP, Hofstetter HH. Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6. Cytokine 2012; 58:231-237.
19. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
20. Volman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 2005; 23:291-297.
21. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 2006; 7:1151-1156.
22. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010; 40:1830-1835.
23. Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O'Shea JJ. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 2010; 21:425-434.
24. Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999; 55:1198-1216.
25. Li H, Gonnella P, Safavi F etal. Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 2012; 254:28-38.
26. Santos RC, Rico MA, Bartrons R, Pujol FV, Rosa JL, de Oliveira JR. The transcriptional activation of the cyclooxygenase-2 gene in zymosan-activated macrophages is dependent on NF-kappa B, C/EBP, AP-1, and CRE sites. Inflammation 2010; 34:653-658.
27. Kimura K, Orita T, Nomi N, Fujitsu Y, Nishida T, Sonoda KH. Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan. Exp Eye Res 2011; 96:157-162.
28. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-650.
29. van de Veerdonk FL, Kullberg BJ, Verschueren IC etal. Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 2010; 34:407-411.